sorafenib has been researched along with Cerebral Pseudosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chubachi, S; Nakagawa, T | 1 |
| De Onzoño, LI; García-Arpa, M; Martinez-Martínez, ML; Rodríguez-Vázquez, M | 1 |
2 other study(ies) available for sorafenib and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
[A Case of Wilson's Disease with Psoriasis Vulgaris, Complicated with Hepatocellular Carcinoma and Successfully Treated with Sorafenib].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatolenticular Degeneration; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Portal Vein; Psoriasis; Recurrence; Sorafenib | 2015 |
Atypical linear toxicodermia by sorafenib.
Topics: Adult; Benzenesulfonates; Biopsy; Edema; Female; Hepatolenticular Degeneration; Humans; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin; Skin Diseases, Papulosquamous; Sorafenib | 2010 |